POS-496 INTERIM ANALYSIS OF THE EAGLE TRIAL: AN OPEN-LABEL STUDY TO ASSESS THE LONG-TERM SAFETY AND TOLERABILITY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME